Addex Therapeutics Posts Narrower Loss In Q3 - Quick Facts

Addex Therapeutics (ADXN) posted a third quarter net loss of 2.7 million Swiss francs compared to a loss of 4.2 million francs in the third quarter of 2022, primarily due to reduced R&D expenses. Loss per share was 0.03 francs compared to a loss of 0.09 francs.

from RTT - Earnings https://ift.tt/qDrO3Jx
via IFTTT